The present study has two major findings: I) In obese patients, the diagnosis of HF was neither associated with increased plasma concentrations of NT-proBNP or MR-proANP nor with increased plasma concentrations of MR-proADM or copeptin, suggesting an overall impaired neurohormonal activation in obesity-related HF. The gene discussed is NPPA; the disease is obesity disorder.